Add Yahoo as a preferred source to see more of our stories on Google. Former President Joe Biden was diagnosed with an "aggressive form" of prostate cancer that spread to the bone, a spokesperson said ...

The Gleason score reliably predicts lethal prostate cancer for up to 25 years after diagnosis. High-grade prostate cancers progress rapidly in the short term, while lower grade tumors can still lead ...

WASHINGTON -- Former President Joe Biden is battling an "aggressive" form of prostate cancer, his office announced on Sunday, adding his condition is characterized by a "Gleason score of 9." His ...

In January 2021, a movement to redefine low-risk Gleason 6 lesions as noncancers or precancers made its debut in this blog under the headline: "Is This Really Cancer?" Urologic oncologist Scott ...

Please provide your email address to receive an email when new articles are posted on . Prolonged androgen deprivation therapy was associated with improved survival among men with Gleason grade groups ...

The issue of Gleason upgrading after diagnostic biopsy is well-documented, but poses a particular concern for men on active surveillance, where an increase in grade can trigger radical intervention.

Sextant biopsies have been routinely used by many urologists, and prostate cancer is often found in multiple biopsy sites from the same patient. Despite extensive studies on the predictive values of ...

Add Yahoo as a preferred source to see more of our stories on Google. Over the weekend, President Joe Biden’s office announced that the former president has prostate cancer that has spread to his ...

Association of baseline prostate atrophy with lower tumor volume in men with prostate cancer on repeat biopsy. Change in a 17-gene genomic prostate score over time in men with low- and ...

Dose escalation with high-dose-3D-conformal/IMRT (HD-3D-CRT/IMRT) compared with low-dose 3D-conformal/IMRT plus HDR brachytherapy (LD-3D-CRT/IMRT+HDR-B) for intermediate- or high-risk prostate cancer: ...

Researchers at the UCLA Jonsson Comprehensive Cancer Center analyzed gene-expression patterns in the most aggressive prostate cancer grade group -- known as Gleason grade group 5 -- and found that ...